35.24
Phibro Animal Health Corp stock is traded at $35.24, with a volume of 144.19K.
It is up +3.54% in the last 24 hours and up +11.20% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$34.03
Open:
$34.66
24h Volume:
144.19K
Relative Volume:
0.41
Market Cap:
$1.43B
Revenue:
$1.50B
Net Income/Loss:
$95.23M
P/E Ratio:
15.14
EPS:
2.328
Net Cash Flow:
$12.77M
1W Performance:
+6.63%
1M Performance:
+11.20%
6M Performance:
-10.83%
1Y Performance:
+20.77%
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp
|
35.24 | 1.38B | 1.50B | 95.23M | 12.77M | 2.328 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Neutral |
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
PAHC|Phibro Animal Health Corp|Price:34.035|Chg%:-0.005 - TradingKey
Phibro Animal Health Corp (PAHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Phibro Animal Health Corp (PAHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Phibro Animal Health Corp (PAHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Phibro Animal Health Corp (PAHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phibro Animal Health Corporatio (PAHC) Stock Forecasts - Yahoo Finance
Phibro Animal Health Corp (PAHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance Australia
Phibro Animal Health Corp (PAHC) Shares Fall 3.5% -- GF Value Sa - GuruFocus
Q3 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain - Yahoo Finance
Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility - Yahoo Finance
Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A - TradingView
MSN Money - MSN
Implied Volatility Surging for Phibro Animal Health Stock Options - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo! Finance Canada
Phibro Q3 FY2026 slides: 10% sales growth amid regulatory headwinds - Investing.com
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares - Investing.com
Phibro (NASDAQ: PAHC) CEO receives 300,000 performance units award - Stock Titan
Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks - Yahoo Finance
Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know - Yahoo! Finance Canada
Phibro Animal Health Corporation(NasdaqGM: PAHC) dropped from Russell 3000E Index - marketscreener.com
Phibro Animal Health Corporation(NasdaqGM: PAHC) dropped from Russell Microcap Index - marketscreener.com
Phibro Animal Health Corporation(NasdaqGM:PAHC) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Phibro Animal Health Corporation 8-K Filing June 2026: Key Details, Trading Symbol, and Company Information - Minichart
Daniel Bendheim named CEO and President of Phibro Animal Health - TradingView
New Phibro (NASDAQ: PAHC) CEO granted 300,000 performance-based RSUs - Stock Titan
Phibro Animal Health Corp (PAHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Paws and profits: adoro Pet Insurance names chief business development officer and other updates - DVM360
PAHC News | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
PAHC - Finviz
Phibro Animal Health Corp (PAHC) Institutional Confidence - TradingKey
Phibro Animal Health Corp (PAHC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Phibro Animal Health Corp (PAHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
What Makes Phibro (PAHC) a New Buy Stock - Yahoo Finance
[144] PHIBRO ANIMAL HEALTH CORP SEC Filing - Stock Titan
Should You Continue to Hold PAHC Stock in Your Portfolio? - Yahoo Finance
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares? - Yahoo Finance
PAHC Stock: What's Driving Phibro's Animal Health Growth - Yahoo Finance
Is PAHC Undervalued at 10x Earnings vs Peers? - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Price Today & Analysis - Gotrade
Phibro Animal Health (PAHC) Q3 2026 Earnings Call Transcript - MLQ.ai
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value - Yahoo Finance
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):